Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BMY
NVO
Add up to 3 more stocks
BMY
Bristol-Myers Squibb Company
-0.91%
$63.52-0.58Delayed quote: Sep 15, 2026, 11:00 AM EDT
Market Cap
$129.74B
52W Range
$42.52 - $68.64
NVO
Novo Nordisk A/S
-2.05%
$42.56-0.89Delayed quote: Sep 15, 2026, 11:00 AM EDT
Market Cap
$188.99B
52W Range
$35.12 - $64.16
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 13.99 | 10.49 |
| Forward P/E | 9.17 | N/A |
| P/B Ratio | 5.81 | 5.60 |
| P/S Ratio | 2.64 | 3.70 |
| P/FCF Ratio | 11.34 | 25.37 |
| EV/EBITDA | 9.69 | 7.77 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 70.2% | 80.6% |
| Operating Margin | 28.3% | 43.1% |
| Net Margin | 18.9% | 35.3% |
| ROE | 41.6% | 53.5% |
| ROA | 10.6% | 19.9% |
| ROIC | 15.5% | 30.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.53 | 0.87 |
| Quick Ratio | 1.38 | 0.66 |
| Debt/Equity | 1.93 | 0.63 |
| Interest Coverage | 7.26 | 30.34 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 3.9% | 4.2% |
| Payout Ratio | 55.3% | 44.3% |
| Yrs of Dividend Growth | 16 | 6 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.